Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duska Dragun

Showing results (111-120 of 136) with videos related to

Pageof 14
Sort By:
Plos One|January 5, 2016
Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient MiceYe Zhu, Maximilian Blum, Uwe Hoff, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 12, 2011
Sex differences in physiological cardiac hypertrophy are associated with exercise-mediated changes in energy substrate availabilityAnna Foryst-Ludwig, Michael C Kreissl, Christiane Sprang, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 12, 2017
Tumour necrosis factor-alpha in uraemic serum promotes osteoblastic transition and calcification of vascular smooth muscle cells via extracellular signal-regulated kinases and activator protein 1/c-FOS-mediated induction of interleukin 6 expressionDaniel Zickler, Christian Luecht, Kevin Willy, et al.
Frontiers in Immunology|October 5, 2023
Expanded Hemodialysis ameliorates uremia-induced impairment of vasculoprotective KLF2 and concomitant proinflammatory priming of endothelial cells through an ERK/AP1/cFOS-dependent mechanismHongfan Zhao, Dashan Wu, Michael Adu Gyamfi, et al.
Cytokine|July 3, 2016
Y-box protein-1/p18 as novel serum marker for ovarian cancer diagnosis: A study by the Tumor Bank Ovarian Cancer (TOC)Irena Rohr, Elena I Braicu, Abdelaziz En-Nia, et al.
International Journal of Molecular Sciences|April 12, 2022
Molecular Effects of Auto-Antibodies on Angiotensin II Type 1 Receptor Signaling and Cell ProliferationAurélie Philippe, Gunnar Kleinau, Jason Jannis Gruner, et al.
Molecular Neurodegeneration|November 16, 2014
Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's diseaseDe-Hyung Lee, Harald Heidecke, Alexandra Schröder, et al.
Frontiers in Immunology|December 3, 2021
Expanded Hemodialysis Therapy Ameliorates Uremia-Induced Systemic Microinflammation and Endothelial Dysfunction by Modulating VEGF, TNF-α and AP-1 SignalingRusan Catar, Guido Moll, Julian Kamhieh-Milz, et al.
Annals of the Rheumatic Diseases|March 12, 2013
Urinary CD4 T cells identify SLE patients with proliferative lupus nephritis and can be used to monitor treatment responsePhilipp Enghard, Claudia Rieder, Katharina Kopetschke, et al.
International Journal of Molecular Sciences|January 11, 2022
Autoantibodies Targeting AT<sub>1</sub>- and ET<sub>A</sub>-Receptors Link Endothelial Proliferation and Coagulation via Ets-1 Transcription FactorRusan Catar, Melanie Herse-Naether, Nan Zhu, et al.
Pageof 14

Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
Plos One|January 5, 2016
Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient MiceYe Zhu, Maximilian Blum, Uwe Hoff, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 12, 2011
Sex differences in physiological cardiac hypertrophy are associated with exercise-mediated changes in energy substrate availabilityAnna Foryst-Ludwig, Michael C Kreissl, Christiane Sprang, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 12, 2017
Tumour necrosis factor-alpha in uraemic serum promotes osteoblastic transition and calcification of vascular smooth muscle cells via extracellular signal-regulated kinases and activator protein 1/c-FOS-mediated induction of interleukin 6 expressionDaniel Zickler, Christian Luecht, Kevin Willy, et al.
Frontiers in Immunology|October 5, 2023
Expanded Hemodialysis ameliorates uremia-induced impairment of vasculoprotective KLF2 and concomitant proinflammatory priming of endothelial cells through an ERK/AP1/cFOS-dependent mechanismHongfan Zhao, Dashan Wu, Michael Adu Gyamfi, et al.
Cytokine|July 3, 2016
Y-box protein-1/p18 as novel serum marker for ovarian cancer diagnosis: A study by the Tumor Bank Ovarian Cancer (TOC)Irena Rohr, Elena I Braicu, Abdelaziz En-Nia, et al.
International Journal of Molecular Sciences|April 12, 2022
Molecular Effects of Auto-Antibodies on Angiotensin II Type 1 Receptor Signaling and Cell ProliferationAurélie Philippe, Gunnar Kleinau, Jason Jannis Gruner, et al.
Molecular Neurodegeneration|November 16, 2014
Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's diseaseDe-Hyung Lee, Harald Heidecke, Alexandra Schröder, et al.
Frontiers in Immunology|December 3, 2021
Expanded Hemodialysis Therapy Ameliorates Uremia-Induced Systemic Microinflammation and Endothelial Dysfunction by Modulating VEGF, TNF-α and AP-1 SignalingRusan Catar, Guido Moll, Julian Kamhieh-Milz, et al.
Annals of the Rheumatic Diseases|March 12, 2013
Urinary CD4 T cells identify SLE patients with proliferative lupus nephritis and can be used to monitor treatment responsePhilipp Enghard, Claudia Rieder, Katharina Kopetschke, et al.
International Journal of Molecular Sciences|January 11, 2022
Autoantibodies Targeting AT<sub>1</sub>- and ET<sub>A</sub>-Receptors Link Endothelial Proliferation and Coagulation via Ets-1 Transcription FactorRusan Catar, Melanie Herse-Naether, Nan Zhu, et al.
Pageof 14